Show simple item record

Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial

dc.contributor.authorMaisel, Alanen
dc.contributor.authorMueller, Christianen
dc.contributor.authorNowak, Richard Men
dc.contributor.authorPeacock, W. Franken
dc.contributor.authorPonikowski, Piotren
dc.contributor.authorMockel, Martinen
dc.contributor.authorHogan, Christopheren
dc.contributor.authorWu, Alan H.B.en
dc.contributor.authorRichards, Marken
dc.contributor.authorClopton, Paulen
dc.contributor.authorFilippatos, Gerasimos S.en
dc.contributor.authorDi Somma, Salvatoreen
dc.contributor.authorAnand, Inderen
dc.contributor.authorNg, Leong L.en
dc.contributor.authorDaniels, Lori B.en
dc.contributor.authorNeath, Sean-Xavieren
dc.contributor.authorChristenson, Roberten
dc.contributor.authorPotocki, Mihaelen
dc.contributor.authorMcCord, Jamesen
dc.contributor.authorHartmann, Oliveren
dc.contributor.authorMorgenthaler, Nils G.en
dc.contributor.authorAnker, Stefan D.en
dc.date.accessioned2016-01-14T13:18:50Zen
dc.date.available2016-01-14T13:18:50Zen
dc.date.issued2011-08-30en
dc.identifier.citationMaisel, A. et al (2011) 'Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial' J. Am. Coll. Cardiol. 58 (10):1057-67en
dc.identifier.issn1558-3597en
dc.identifier.pmid21867843en
dc.identifier.doi10.1016/j.jacc.2011.06.006en
dc.identifier.urihttp://hdl.handle.net/10547/593474en
dc.description.abstractThe aim of this study was to determine the prognostic utility of midregion proadrenomedullin (MR-proADM) in all patients, cardiac and noncardiac, presenting with acute shortness of breath.
dc.language.isoenen
dc.publisherAmerican College of Cardiologyen
dc.relation.urlhttp://content.onlinejacc.org/article.aspx?articleid=1206940en
dc.rightsArchived with thanks to Journal of the American College of Cardiologyen
dc.subjectmidregion proadrenomedullinen
dc.subjectMR-proADMen
dc.subjectshortness of breathen
dc.subject.meshAdrenomedullinen
dc.subject.meshAgeden
dc.subject.meshAged, 80 and overen
dc.subject.meshBiomarkersen
dc.subject.meshDyspneaen
dc.subject.meshHeart Failureen
dc.subject.meshHumansen
dc.subject.meshMiddle Ageden
dc.subject.meshMultivariate Analysisen
dc.subject.meshPredictive Value of Testsen
dc.subject.meshPrognosisen
dc.subject.meshProspective Studiesen
dc.subject.meshProtein Precursorsen
dc.titleMidregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trialen
dc.typeArticleen
dc.contributor.departmentVA San Diego Healthcare Systemen
dc.contributor.departmentSan Diego Veterans Affairs Medical Centeren
dc.contributor.departmentUniversity Hospital Baselen
dc.contributor.departmentHenry Ford Health Systemen
dc.contributor.departmentThe Cleveland Clinicen
dc.contributor.departmentCharité Medical Schoolen
dc.contributor.departmentVirginia Commonwealth Universityen
dc.contributor.departmentUniversity of Californiaen
dc.contributor.departmentUniversity of Otagoen
dc.contributor.departmentAthens University Hospital Attikonen
dc.contributor.departmentUniversity La Sapienzaen
dc.contributor.departmentB·R·A·H·M·S Aktiengesellschaft Biotechnology Centreen
dc.contributor.departmentIRCCS San Raffaele, Romeen
dc.identifier.journalJournal of the American College of Cardiologyen
html.description.abstractThe aim of this study was to determine the prognostic utility of midregion proadrenomedullin (MR-proADM) in all patients, cardiac and noncardiac, presenting with acute shortness of breath.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record